1. From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs

    By Vandana Singh Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as patents for some of the industry's blockbuster drugs are on the expir